A Minimally Invasive Test That Can Support Accurately Assigning the Origin of Detected cfDNA From Donors in Patients With Two Kidney Transplants

This on-demand webinar provides an overview of detecting donor-derived cell-free DNA (dd-cfDNA) in patients with two kidney transplants. Learn more about how dd-cfDNA is used for post-transplant monitoring, the impact of circulating dd-cfDNA from more than one donor, and the use of insertions and deletion variants (indels) versus single-nucleotide polymorphisms (SNPs) using next-generation sequencing (NGS).

Learning objectives:

How dd-cfDNA is used for post-transplant monitoring
Investigate the impact of circulating dd-cfDNA in patients with two kidney transplants
Understand the use of indels vs. SNPs in NGS

Guest the speaker:

Jakob Nilsson, MD, PhD,
Consultant Physician, Director Transplant Immunology, Department of Immunology, University Hospital Zurich, Switzerland

First name

Last name

Country / Region

To ensure that we are complying with your preferences, we need to confirm permission to send you communications by email. Personal information provided will be used in accordance with our Privacy Policy.

Please confirm you would like to receive marketing and promotional email messages about products and services from Thermo Fisher Scientific and its brands in accordance with our privacy statement. By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Thermo Fisher Scientific Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Product is CE-IVD marked but not 510(k)-cleared. Availability of product in each country depends on local regulatory marketing authorization status.